Health Policy

ISSN:

影响因子:

SCIE收录情况:

JCR分区 ▼
Mathieu Charbonneau ; Mathieu Charbonneau ; Steven G. Morgan ; Camille Gagnon ; Cheryl A. Sadowski ; James L. Silvius ; Cara Tannenbaum ; Justin P. Turner

亮点

  • We review system-level policies to promote appropriate use of medicines.
  • The most effective policies engage and provide support to multiple stakeholders.
  • Clear national strategies foster successful prescribing appropriateness interventions.
  • Some degree of central coordination, through national medicine agencies, is key.

摘要

Background

The appropriate use of medicines has long been recognized as a fundamental component of medicine policies. We aimed to extract lessons from published research on how policy contexts and mechanisms can affect the outcomes of national- or health-system level interventions to promote appropriate medicine use (defined as an increase in underutilized medications or decrease in inappropriate medication use).

Methods

We conducted a rapid realist review of published evidence concerning system-level policies to promote the appropriate use of medicines in high-income countries with universal prescription drug coverage. We searched MEDLINE and Embase to identify relevant publications. We used a realist evaluation framework to identify contexts, mechanisms, and outcomes for each intervention and to hypothesize which policy contexts and mechanisms supported successful outcomes in terms of relative changes in the prevalence of use of the specific medication classes targeted.

Results

From 1,318 identified studies, 18 met our inclusion criteria. 13 distinct policies were identified. Three main policy-related factors underpinned successful interventions: involving providers and patients through program interventions; central coordination through national agencies dedicated to medicine policies; and the establishment of an explicit and integrated national medicine policy strategy.

Conclusion

Policymakers can improve coordination of national pharmaceutical policies to reduce harms from inappropriate medicines use, thus improving health outcomes through cost-effective programs.

Appropriate medicine use; Prescribing appropriateness; Realist review; National medicines policies; Pharmaceutical policy

10.5

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。